| Announce Date | 12/02/2025 |
| EPS Normalized Actual | $0.528 (Beat by $0.098) |
| EPS GAAP Actual | $0.528 (Beat by $0.098) |
| Revenue Actual | $1.3627B |
| Revenue Surprise | Beat by $1362.7M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2028 | 1.0541 | 22.54 | 1.03107 | 1.06594 | 1 |
| Feb 2028 | 1.44846 | 16.4 | 1.41963 | 1.48523 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.54 | 0.54 | 1.3627B | 5.4% | 1362.7M |
| FQ3 2025 (Aug 2025) | 0.45 | 0.45 | 1.28368B | 100% | 1283.68M |
| FQ2 2025 (May 2025) | -0.36 | -0.36 | 1.0896B | 100% | 1089.6M |
| FQ1 2025 (Feb 2025) | 0.54 | 0.54 | 1.60463B | 100% | 1604.63M |
| FQ4 2024 (Nov 2024) | 0.42 | 0.42 | 1.28909B | 100% | 1289.09M |
| FQ1 1997 (Feb 1997) | 0.65 | 0.65 | 0.122905B | 100% | 122.91M |
| FQ3 2023 (Jul 2023) | 0.25 | 0.25 | 1.20088B | 100% | 1200.88M |
| FQ2 2023 (Apr 2023) | 0.09 | 0.09 | 1.08093B | 100% | 1080.93M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 0.63597 | -- | 0.62134 | 0.65034 | 5 |
| FQ4 2027 (Nov 2027) | 0.51479 | -- | 0.50331 | 0.52821 | 4 |
| FQ3 2027 (Aug 2027) | 0.43464 | -- | 0.42495 | 0.44597 | 4 |
| FQ2 2027 (May 2027) | -0.012227 | -- | -0.01254574 | -0.01195441 | 4 |
| FQ1 2027 (Feb 2027) | 0.63414 | -- | 0.62658 | 0.64252 | 4 |
| FQ4 2026 (Nov 2026) | 0.52916 | -2.05 | 0.5212 | 0.53776 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 1.63B | -- | 1.6B | 1.65B | 3 |
| FQ4 2027 (Nov 2027) | 1.41B | -- | 1.39B | 1.44B | 2 |
| FQ3 2027 (Aug 2027) | 1.35B | -- | 1.32B | 1.38B | 2 |
| FQ2 2027 (May 2027) | 1.14B | -- | 1.12B | 1.17B | 2 |
| FQ1 2027 (Feb 2027) | 1.68B | -- | 1.67B | 1.7B | 4 |
| FQ4 2026 (Nov 2026) | 1.34B | -1.66 | 1.32B | 1.36B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.54 | 0.54 | 100% | |
| FQ3 2025 (Aug 2025) | 0.45 | 0.45 | 100% | |
| FQ2 2025 (May 2025) | -0.36 | -0.36 | 100% | |
| FQ1 2025 (Feb 2025) | 0.54 | 0.54 | 100% | |
| FQ4 2024 (Nov 2024) | 0.42 | 0.42 | 100% | |
| FQ1 1997 (Feb 1997) | 0.65 | 0.65 | 100% | |
| FQ3 2023 (Jul 2023) | 0.25 | 0.25 | 100% | |
| FQ2 2023 (Apr 2023) | 0.09 | 0.09 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $1.36B | $1362.7M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $1.28B | $1283.68M | 100% |
| FQ2 2025 (May 2025) | $0B | $1.09B | $1089.6M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $1.6B | $1604.63M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $1.29B | $1289.09M | 100% |
| FQ1 1997 (Feb 1997) | $0B | $0.12B | $122.91M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $1.2B | $1200.88M | 100% |
| FQ2 2023 (Apr 2023) | $0B | $1.08B | $1080.93M | 100% |